Doug Bevan

Title: Doug Bevan: Innovator in Pharmaceutical Chemistry

Introduction

Doug Bevan is a notable inventor based in Chelmsford, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development of innovative compounds with therapeutic applications.

Latest Patents

Among his latest patents, Doug Bevan has developed indane and indoline derivatives that serve as soluble guanylate cyclase activators. The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also includes a method for manufacturing these compounds and outlines their therapeutic uses. Furthermore, the invention presents a combination of pharmacologically active agents and a pharmaceutical composition.

Career Highlights

Doug Bevan is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore and innovate in the realm of pharmaceutical development, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Doug has collaborated with esteemed colleagues, including Christopher Michael Adams and Takeru Ehara. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Doug Bevan's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to impact the development of therapeutic agents, showcasing the importance of innovation in healthcare.